Pfizer's Says Company "Very" Big Balance Sheet for Deals
Pfizer signals it can bankroll ambitious deals with a robust balance sheet. This article weighs what a 'very big' bal...
Pfizer
This Pfizer tag page curates 3 articles examining stock potential, key risks, and long-term strategies. It helps you assess impact on your finances and make informed moves.
25 articlesPfizer Verizon Communications: Which High-Yield Stock Wins
Dividend investors face a crowded field. This article compares Pfizer and Verizon Communications to answer pfizer ver...
Pfizer Could Prove Underrated GLP-1 Stock Opportunity
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Could Pfizer Stock Your Path to Generational Wealth
Pfizer’s stock has faced waves of headwinds, but a patient, long-term view can reveal an opportunity. This guide expl...
Stock Market Today, June: Pfizer CFO Transition Signals 2026
Investors weigh Pfizer's CFO transition as the broader market climbs. This look at the stock market today, june revea...
Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Lexicon Pharmaceuticals Pfizer: Which Stock Is Best Buy 2026
In 2026, investors face a choice between a nimble biotech player and a global pharma titan. This guide compares Lexic...
Prediction: Pfizer Stock Could Double If Pipeline Delivers
Pfizer stock is navigating a pivot from COVID-era revenues to a broader drug portfolio. Analysts weigh the odds of a ...
Insiders Aren’t Buying Pfizer Stock, and That Could Help
Pfizer stock hovers around the $26 level as insiders aren’t buying Pfizer stock. Analysts point to a patient, value-f...
Wall Street Analyst Thinks Pfizer Stock Could Soar 38% This Week
A single wall street analyst thinks Pfizer's stock could spark a meaningful rally. Learn the catalysts, risks, and ho...